BARCLAYS PLC: MP position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on MP, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 203,576 MP shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 203,576 sharesChange vs previous 13F +7,006 shares
<0.01% of the 13F portfolio, value $11,402,292.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 196,570 sharesChange vs previous 13F -33,498 shares
<0.01% of the 13F portfolio, value $9,486,468.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 230,068 sharesChange vs previous 13F +68,023 shares
0.01% of the 13F portfolio, value $15,430,661.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 162,045 sharesChange vs previous 13F +40,653 shares
<0.01% of the 13F portfolio, value $3,955,519.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 121,392 sharesChange vs previous 13F +72,868 shares
<0.01% of the 13F portfolio, value $1,893,715.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 48,524 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $856,449.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).